Cantor Fitzgerald Reiterates Overweight Rating on Eli Lilly (LLY) Ahead of Conference Call
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,180.16 -2.25%
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $143.00 price target on Eli Lilly (NYSE: LLY) ahead of a conference call to discuss Alzheimer’s disease treatment landscape and what to expect at CTAD.
For an analyst ratings summary and ratings history on Eli Lilly click here. For more ratings news on Eli Lilly click here.
Shares of Eli Lilly closed at $117.35 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intuitive Machines Inc. (LUNR) PT Lowered to $32 at Cantor Fitzgerald, Reaffirms Overweight Rating
- Cantor Fitzgerald Downgrades Better Home & Finance Holding (BETR) to Neutral
- Cantor Fitzgerald Reiterates Overweight Rating on Merlin Labs (MRLN)
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Cantor Fitzgerald, Louise ChenSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
